Review of new oral anticoagulants

Lindsay Frye; Heather Katz; Natasha Bray; Barry Berman

Review of new oral anticoagulants

Lindsay Frye, Heather Katz, Natasha Bray, Barry Berman

Administration and Leadership

Research output: Contribution to journal › Review article › peer-review

Abstract

New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.

Original language	English
Pages (from-to)	8-15
Number of pages	8
Journal	Osteopathic Family Physician
Volume	7
Issue number	3
State	Published - 1 May 2015

Keywords

Anticoagulation
Atrial fibrillation
Deep vein thrombosis
Pulmonary embolus
Warfarin

Cite this

@article{0840bcc014474262bf13b73581cc696f,

title = "Review of new oral anticoagulants",

abstract = "New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.",

keywords = "Anticoagulation, Atrial fibrillation, Deep vein thrombosis, Pulmonary embolus, Warfarin",

author = "Lindsay Frye and Heather Katz and Natasha Bray and Barry Berman",

year = "2015",

month = may,

day = "1",

language = "English",

volume = "7",

pages = "8--15",

journal = "Osteopathic Family Physician",

issn = "1877-573X",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Review of new oral anticoagulants

AU - Frye, Lindsay

AU - Katz, Heather

AU - Bray, Natasha

AU - Berman, Barry

PY - 2015/5/1

Y1 - 2015/5/1

N2 - New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.

AB - New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Deep vein thrombosis

KW - Pulmonary embolus

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=85050369092&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:85050369092

SN - 1877-573X

VL - 7

SP - 8

EP - 15

JO - Osteopathic Family Physician

JF - Osteopathic Family Physician

IS - 3

ER -

Review of new oral anticoagulants

Abstract

Keywords

Other files and links

Fingerprint

Cite this